Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis

American Journal of Infection Control

Volumn 37, Issue 1, 2009, Pages 56-64

  Cetin, Emel Sesli ^a   Durmaz, Riza ^b   Tetik, Tulay ^a   Otlu, Bariş ^b   Kaya, Selcuk ^a   Çalişkan, Ahmet ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; CATHETERIZATION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; TEACHING HOSPITAL; TRACHEAL ASPIRATION PROCEDURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CATHETERIZATION; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; RESPIRATION, ARTIFICIAL; RISK FACTORS; TURKEY;

EID: 58549111863     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.01.010     Document Type: Article

References (37)

1. Ecker J.A., Massire C., Hall T.A., Ranken R., Pennella T.T., Agasino Ivy C., et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 44 (2006) 2921-2932
2. Forbes B.A., Sahm D.F., and Weissfeld A.S. Acinetobacter, Chryseomonas, Flavimonas, and Stenotrophomonas. In: Forbes B.A., Sahm D.F., and Weissfeld A.S. (Eds). Bailey & Scott's diagnostic microbiology. 11th ed. (2002), Mosby 378-383
3. Bergogne-Berezin E., and Towner K.J. Acinetobacter spp as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 9 (1996) 148-165
4. Bergogne-Berezin E. The increasing role of Acinetobacter species as nosocomial pathogens. Curr Infect Dis Rep 3 (2001) 440-444
5. Paul M., Weinberger M., Siegman-Igra Y., Lazarovitch T., Ostfeld I., Boldur I., et al. Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 60 (2005) 256-260
6. Wright M.O. Multi-resistant gram-negative organisms in Maryland: a statewide survey of resistant Acinetobacter baumannii. Am J Infect Control 33 (2005) 419-421
7. Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., and Winn W.C. The nonfermentative gram-negative bacilli. In: Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., and Winn W.C. (Eds). Color atlas and textbook of diagnostic microbiology. 4th ed. (1997), J.P. Lippincott Co., Philadelphia 213-214
8. Friedland I., Stinson L., Ikaiddi M., Harm S., and Woods G.L. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a multicenter intensive care unit surveillance study, 1995-2000. Diagn Microbiol Infect Dis 45 (2003) 245-250
9. Wroblewska M.M., Towner K.J., Marchel H., and Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect 13 (2007) 490-496
10. Zarrilli R., Crispino M., Bagattini M., Barretta E., Popolo A.D., Triassi M., et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 42 (2004) 946-953
11. Salazar de Vegas E.Z., Nieves B., Ruiz M., Ruíz J., Vila J., María A., et al. Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela. Med Sci Monit 27 (2007) 13
12. Zarrilli R., Casillo R., Di Popolo A., Tripodi M.F., Bagattini M., Cuccurullo S., et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin Microbiol Infect 13 (2007) 481-489
13. Tenover F.C., Arbeit R.D., and Goering R.V. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 18 (1997) 426-439
14. Prashanth K., and Badrinath S. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR and pulsed-field gel electrophoresis. Indian J Med Res 122 (2005) 408-418
15. Gaynes R.P., and Horan T.C. Surveillance of nosocomial infections. In: Mayall C.G. (Ed). Hospital epidemiology and infection control (1996), The Williams & Wilkins Co., Baltimore, MD 1017-1031
16. Durmaz R., Otlu B., Çalişkan A., and Gürsoy N. A rapid pulsed-field gel electrophoresis protocol developed for subtyping Acinetobacter baumannii, Escherichia coli, and Klebsiella spp. ANKEM Derg 21 (2007) 113-117
17. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
18. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; M100-S15, 15th informational supplement (2005), CLSI, Wayne, PA
19. Jones R.N., Anderegg T.R., Swenson J.M., and The Quality Control Working Group. Quality control guidelines for testing gram-negative control strains with polymyxin b and colistin (polymyxin E) by standardized methods. J Clin Microbiol 43 (2005) 9257
20. Jones R.N., Ferraro M.J., Reller L.B., Schreckenberger P.C., Swenson J.M., and Sader H.S. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45 (2007) 227-230
21. Bradford P.A., and Sanders C.C. Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam. Antimicrob Agents Chemother 36 (1992) 394-400
22. Prashanth K., and Badrinath S. Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Ind J Med Microbiol 24 (2006) 39-44
23. Van Looveren M., Goossens H., and Arpac Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10 (2004) 684-704
24. Nemec A., Dijkshoorn L., and van der Reijden T.J. Long-term predominance of two pan-European clones among multiresistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 53 (2004) 147-153
25. van Dessel H., Dijkshoorn L., van der Reijden T., et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155 (2004) 105-112
26. Villari P., Iacuzio L., Vozzella E.A., and Bosco U. Unusual genetic heterogeneity of Acinetobacter baumanni isolates in a university hospital in Italy. Am J Infect Control 27 (1999) 247-253
27. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) 104-113
28. Manikal V.M., Landman D., Saurina G., Oydna E., Lal H., and Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31 (2000) 101-106
29. Vila J., Ruiz J., Navia M., Becerril B., Garcia I., Perea S., et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 37 (1999) 758-761
30. Maslow J.N., Slutsky A.M., and Arbeit R.D. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing H.D., Smith T.F., Tenover F.C., and White T.J. (Eds). Diagnostic molecular microbiology: principles and applications (1993), American Society for Microbiology, Washington, DC 563-572
31. Falagas M.E., and Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64 (2006) 7-15
32. Go E.S., Urban C., Burns J., Kreiswirth B., Eisner W., Mariano N., et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344 (1994) 1329-1332
33. Cetin E.S., Kaya S., Tetik T., and Aridogan B.C. Distribution and antibiotic susceptibility of Acinetobacter baumannii strains isolated from clinical samples. ANKEM Derg 20 (2006) 202-205
34. Corbella X., Montero A., Pujol M., Dominguez M.A., Ayats J., Argerich M.J., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38 (2000) 4086-4095
35. Poirel L., and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12 (2006) 826-836
36. Li J., Nation R.L., Milne R.W., Turnidge J.D., and Coulthard K. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int J Antimicrobial Agents 25 (2005) 11-25
37. Helio S.S., Jonesa R.N., Dowzicky M.J., and Fritschea T.R. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 52 (2005) 203-208